|
⚲
|
| Keyboard |
| Foley Mark J
✚
|
|
|---|---|
| CIK # | 0001529196 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001529196] | |
| 4 | [0001529196] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| GLAUKOS Corp | |
| Foley Mark J | |
| Revance Therapeutics Inc | |
| Si-Bone Inc | |
| Zeltiq Aesthetics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
GLAUKOS Corp GKOS
Common Stock
|
2026-01-02 | Grant | 1,168 | $0.00 | |
|
GLAUKOS Corp GKOS
Common Stock
|
2025-05-29 | Grant | 2,108 | $0.00 | |
|
GLAUKOS Corp GKOS
Stock Option (Right to Buy) · derivative
|
2025-05-29 | Grant | 3,149 | $0.00 | |
|
GLAUKOS Corp GKOS
Common Stock
|
2025-02-26 | Sell | 20,687 | $120.72 | 2,497,335 |
|
GLAUKOS Corp GKOS
Stock Option (Right to Buy) · derivative
|
2025-02-26 | Option exercise | 15,000 | $0.00 | |
|
GLAUKOS Corp GKOS
Common Stock
|
2025-02-26 | Option exercise | 15,000 | $24.69 | 370,350 |
|
GLAUKOS Corp GKOS
Common Stock
|
2025-02-26 | Option exercise | 25,000 | $32.00 | 800,000 |
|
GLAUKOS Corp GKOS
Stock Option (Right to Buy) · derivative
|
2025-02-26 | Option exercise | 25,000 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-06 | Disposed to issuer | 84,686 | ||
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-06 | Grant | 84,686 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-06 | Disposed to issuer | 27,933 | ||
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-04 | Tender | 996,935 | $3.65 | 3,638,813 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-04 | Tender | 110,913 | $3.65 | 404,832 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-03 | Grant | 27,933 | $0.00 | |
|
GLAUKOS Corp GKOS
Common Stock
|
2025-01-02 | Grant | 864 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2024-12-31 | Grant | 1,000 | $2.18 | 2,180 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2024-06-30 | Grant | 1,000 | $2.18 | 2,180 |
|
GLAUKOS Corp GKOS
Common Stock
|
2024-05-30 | Grant | 1,716 | $0.00 | |
|
GLAUKOS Corp GKOS
Stock Option (Right to Buy) · derivative
|
2024-05-30 | Grant | 1,246 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2024-03-15 | Tax withheld | 3,305 | $5.31 | 17,550 |
| showing 20 of 200 most recent transactions | |||||